Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Endocrine 1Dermatologic 1

Conditions

Multiple Myeloma 154Lymphoma 78Lymphoma, Non-Hodgkin 62Neoplasms, Plasma Cell 54Leukemia 52Leukemia, Myeloid, Acute 49Hodgkin Disease 48Precursor Cell Lymphoblastic Leukemia-Lymphoma 45Leukemia, Lymphocytic, Chronic, B-Cell 45Myelodysplastic Syndromes 42Lymphoma, Large B-Cell, Diffuse 41Lymphoma, Follicular 40Lymphoma, Mantle-Cell 38Lymphoma, Large-Cell, Immunoblastic 29Neuroblastoma 27Burkitt Lymphoma 27Lymphoma, B-Cell, Marginal Zone 26Recurrence 22Immunoglobulin Light-chain Amyloidosis 22Myeloproliferative Disorders 18Leukemia, Myeloid, Accelerated Phase 16Hematologic Neoplasms 16Congenital Abnormalities 16Leukemia, Myeloid, Chronic-Phase 14Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14Graft vs Host Disease 14Dendritic Cell Sarcoma, Interdigitating 14Waldenstrom Macroglobulinemia 13Leukemia, Myelomonocytic, Chronic 13Blast Crisis 13

Interventions

Gemcitabine 23Capecitabine 17Cisplatin 11Oxaliplatin 10Fluorouracil 9Leucovorin 8Irinotecan 7Erlotinib Hydrochloride 6pembrolizumab 5Radiotherapy 5Sorafenib 4Interleukin-12 Subunit p35 3Cholangiopancreatography, Endoscopic Retrograde 3Carboplatin 3regorafenib 2dehydroftorafur 2Watchful Waiting 2Trastuzumab 2Pancreaticoduodenectomy 2N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2Long-Term Synaptic Depression 2Lapatinib 2Filgrastim 2Epirubicin 2Drug Therapy 2Dihematoporphyrin Ether 2Chemotherapy, Adjuvant 2Bevacizumab 2trifluridine tipiracil drug combination 1tremelimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Bile Duct Neoplasms × Melphalan × Clear all
NCT00096083 2013-10-23

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Delcath Systems Inc.

Phase 2 Completed
56 enrolled
DermatologicEndocrineGastrointestinal

Adenocarcinoma Of Esophagus, Uveal Melanoma, Appendiceal Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Vipoma, Esophageal Neoplasms, Gallbladder Neoplasms, Glucagonoma, Carcinoma, Hepatocellular, Insulinoma, Melanoma, Neoplasms, Pancreatic Neoplasms, Pheochromocytoma, Rectal Neoplasms, Somatostatinoma, Stomach Neoplasms, Carcinoma, Islet Cell, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡